跳至主要内容
临床试验/IRCT201710089014N193
IRCT201710089014N193招募中2 期

Comparison of the therapeutic effect of allopurinol versus placebo on clinical signs and symptoms in patients with manic bipolar disorder: a double blind randomized clinical trial

Vice-chancellor for Research and Technology, Zahedan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
All

入选标准

  • Age of 18 to 45 years; manic bipolar disorder; Score of YMRS equal to or greater than28.
  • Exclusion criteria: Pregnancy; breastfeeding; sensitivity to allopurinol; mental disability; diabetes; hypertension; hypothyroiditis; hyperthyroiditis; convulsion; liver failure; renal failure.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for Research and Technology, Zahedan University of Medical Sciences

相似试验